Vanguard Therapeutics


Vanguard Therapeutics is an early stage California company that is developing a disease changing, orally absorbable, cell adhesion-blocking drug for prophylactic therapy of sickle cell disease (SCD).

Vanguard Therapeutics is an early stage California company that is developing a disease changing, orally absorbable, cell adhesion-blocking drug for prophylactic therapy of sickle cell disease (SCD).

Company (Alive / Active)

Phone: 415-203-0436

Fax:

108 Eagle Trace Drive

Half Moon Bay, 94019
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Vanguard Therapeutics $4.2M Feb 15, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Vanguard Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Small Business Innovation Research AwardsGovernmentWashington, DC, United StatesGrant
JLabsIncubator/AcceleratorSan Diego, California, United StatesIncubator/Accelerator
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)